[fk_cart_menu]
[fk_cart_menu]

Secretagogue Peptide

CJC-1295 / Ipamorelin

A strategic peptide combination engineered to enhance GH release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.

Dosage
Quantity
$59.99
BUNDLE & SAVE

Fri, May 8 - Thu, May 14

Free shipment protection

Overnight shipping available

We Accept

Free shipping

on orders over $150

Damage

protection

Secure checkout

256-bit SSL

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

99.94%

PURITY

Variant:

CJC-1295 / Ipamorelin (5mg / 5mg)

Lot #:

D3123

Labeled:

10mg blend

Actual:

12.02mg total

Ipamorelin:

6.13mg

CJC-1295:

5.89mg

Tested:

Feb 4, 2026

Compound Information

Technical specifications

CJC-1295 (NO DAC)

GHRH Analog Component

Other names:

Mod GRF 1-29, Modified GRF

Type:

GHRH analog

Acids:

29

Molecular Weight:

~3,367 g/mol

Mechanism:

GHRH receptor agonist

Half-life (No DAC):

30 min - 2 hours

IPAMORELIN

Selective GHRP Component

Type:

Growth hormone secretagogue

Acids:

5 (pentapeptide)

Molecular Weight:

711.85 g/mol

Sequence:

Aib-His-D-2-Nal-D-Phe-Lys-NH2

Mechanism:

Ghrelin receptor (GHSR-1a) agonist

Selectivity:

No cortisol/prolactin elevation

BLEND INFORMATION

Why This Combination

Typical ratio:

1:1 by weight

Combined half-life:

1-2 hours (functional)

Synergy factor:

~2.7x vs single pathway

Route:

Subcutaneous injection

Sources & References

Peer-reviewed research

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-...

2006 • DOI: 10.1210/jc.2… • PMID: 16352683
Teichman SL, Neale A, Lawrence B et…

EUROPEAN JOURNAL OF ENDOCRINOLOGY

Ipamorelin, the first selective growth hormone secretagogue

1998 • DOI: 10.1530/eje…. • PMID: 9849822
Raun K, Hansen BS, Johansen NL et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

On the actions of the growth hormone-releasing hexapeptide, GHRP

1991 • PMID: 1919399
Bowers CY, Reynolds GA, Durham D e…

TRANSLATIONAL ANDROLOGY AND UROLOGY

A Review of Growth Hormone Secretagogues

2018 • DOI: 10.21037/ta… • PMID: 30186644
Sigalos JT, Pastuszak AW

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Growth Hormone and Its Secretagogues on Bone

1998 • PMID: 9851737
Svensson J, Ohlsson C, Jansson JO et…

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Once-Daily Administration of CJC-1295, a Long-Acting Growth Hormone-Releasing Hormone (GHR...

2006 • DOI: 10.1210/jc.2… • PMID: 16670169
Alba M, Fintini D, Sagazio A et al.

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

All the research peptides you need, with the peace of mind and research community at your fingertips.

Research updates from The Glow Club

Subscribe for catalog updates, new research compounds, and quality documentation news

For researchers and labs. No spam, unsubscribe anytime.

Researcher verification

Glow Club sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By entering, you confirm you meet the qualifications above. Glow Club products are sold for research use only and are not intended for human consumption.

Not a researcher? Exit